You are invited to join Drs. Johan Gabrielsson and Daniel Weiner for the 14th Advanced Level Workshop on Pharmacokinetic - Pharmacodynamic Data Analysis. Learn to apply advanced approaches for conducting PK/PD analysis. This course has updated content: hands-on problem solving that will include an introduction to population PK/PD modeling.
Course date and location: Munich, Germany from May 12-15, 2014 Topics include: Dose-response-time analysis, advanced principles of turnover modeling including modeling tolerance and rebound, approaches to TMDD modeling, approaches to optimizing sampling collection times, modeling PD effects for combination drug treatments, pattern recognition, and translational aspects of PK/PD modeling. Course includes: * Complimentary copy of Pharmacokinetic & Pharmacodynamic Data Analysis [with CD-ROM] by Gabrielsson & Weiner * Lectures, group exercises with discussion, and hands-on PK/PD data analysis including population PK/PD modeling using Phoenix WinNonlin and NLME * Discussions and exercises will enable participants to master state-of-the-art approaches to real-life problems Who should attend? Scientists with at least 5 years of experience in PK/PD modeling Get more information and register at www.certara.com/training<http://www.certara.com/training>! Any questions about the course? Email [email protected]<mailto:[email protected]>. Don't miss this opportunity to increase your confidence in understanding basic and advanced approaches to PK/PD modeling and to apply these approaches using population methods. Sincerely, Suzanne Minton, PhD Marketing Specialist Certara(tm) Implementing Translational Science 5520 Dillard Dr., Suite 260, Cary, NC 27518 Tel +1-919-852-4636 Certara: The name behind the names you know Tripos - Simcyp - Pharsight www.certara.com<http://www.certara.com/> NOTICE: The information contained in this electronic mail message is intended only for the personal and confidential use of the designated recipient(s) named above. This message may be an attorney-client communication, may be protected by the work product doctrine, and may be subject to a protective order. As such, this message is privileged and confidential. If the reader of this message is not the intended recipient or an agent responsible for delivering it to the intended recipient, you are hereby notified that you have received this message in error and that any review, dissemination, distribution, or copying of this message is strictly prohibited. If you have received this communication in error, please notify us immediately by telephone and e-mail and destroy any and all copies of this message in your possession (whether hard copies or electronically stored copies). Thank you. buSp9xeMeKEbrUze
